Dear colleagues,

We are delighted to announce the first open scientific seminar of LabCom DECIPHER, taking place on 25 September 2026 at the CIRM, Luminy Campus, Marseille.

The morning will bring together academic, clinical and industrial partners to discuss cancer treatment resistance, ALDH-targeted therapies, the ODYSSEY clinical trial, and the integration of multi-omics and genomic screening to identify new therapeutic opportunities. A networking cocktail will follow at the TAGC. Representatives from INSERM, ANR and A*Midex will also join us.

We are pleased to share the programme and look forward to stimulating exchanges and discussions.

Registration is required via RENATER:

https://evento.renater.fr/survey/journee-labcom-decipher-h6rkqpcl

Follow us on LinkedIn

https://www.decipher-labcom.fr

------------------------------------------

Salvatore Spicuglia, PhD
Functional genomics of normal and leukemic T cells

LIGUE team - Equipe Labellisée Ligue Contre le Cancer

TAGC - Theories and Approaches of Genomic Complexity

Inserm – Aix-Marseille University U1090. Case 928

163, Avenue de Luminy

13288 MARSEILLE cedex 09

Mobile: +33 (0)6 99 02 48 41

Phone: +33 (0)4 91 82 87 17

https://tagc.univ-amu.fr/en/directory/salvatore-spicuglia